Researchers discuss how blood pressure can influence dementia risks and report raising diastolic blood pressure through daily soleus muscle, or calf muscle, stimulation can help reverse signs of cognitive decline associated with aging.
Lower blood levels of amyloid-beta 42 during mid-life were associated with a higher risk of dementia and a marginally increased risk of mild cognitive impairment later in life, a new study reports.
The release of 2-AG, a natural endocannabinoid that is suggested to be the brain's equivalent to THC, dampens down seizure activity but increases post-seizure oxygen deprivation in the brain.
A small increase in fine particular air pollution over a decade within certain areas of Seattle was associated with significantly increased dementia risks for those living in the areas.
An experimental small molecule helped restore the removal of mitochondria from dopamine-producing neurons in the brain. The findings may help in the development of new therapies for Parkinson's disease.
A new hydrogel that acts as a gateway to transfer stem cells into the brain and facilitate repair to damaged tissue may effectively treat neurological conditions like Parkinson's disease and stroke.
15 protein biomarkers have been identified as being linked to late-onset dementias. The biomarkers can predict cognitive decline and risk for dementia up to 20 years before the onset of symptoms.
60% of 400 coronavirus survivors experienced lasting cognitive impairment, a new study reports. Cognitive problems were found in those who experienced mild-to-moderate COVID symptoms, as well as those who experienced more severe symptoms. One in three of the survivors experienced severe cognitive symptoms, akin to dementia.
Researchers believe they have found a cause of memory loss in epilepsy patients by recording single neurons in the brain.
A new system translates EEG data into a 3D movie which shows activity in all recorded regions of the brain. The heat map shows where seizures start and spread throughout the patient's brain, in addition to evaluating the speed of activity during a seizure.
Riluzole, a drug commonly prescribed to slow the progression of ALS, appears to slow brain metabolic decline and improve cognitive performance in those with mild Alzheimer's disease.
Findings reveal how individual neurons in the thalamus can merge signals coming from different regions of the cortex. The findings could lead to new treatment options for schizophrenia, epilepsy, and other brain disorders where thalamus dysfunction is related to clinical symptoms.